Prognostic value of deep sequencing method for minimal residual disease detection in multiple myelomaJoaquín Martínez‐López, Ramón García‐Sánz, María Ángeles Montalbán et al.|Blood|2014Cited by 429
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myelomaLaura Rosiñol, Joan Bladé, Albert Oriol et al.|Blood|2019Cited by 218
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortalityJoaquín Martínez‐López, Jesús F. San Miguel, Juan José Lahuerta et al.|Blood Cancer Journal|2020Cited by 78
Clinical applicability and prognostic significance of molecular response assessed by fluorescent‐<scp>PCR</scp>of immunoglobulin genes in multiple myeloma. Results from a<scp>GEM</scp>/<scp>PETHEMA</scp>studyJoaquín Martínez‐López, Elena Fernández‐Redondo, Ramón García‐Sánz et al.|British Journal of Haematology|2013Cited by 29